4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-096517
Chief Medical Officer sold 904 shares at $14.90 ($13,470)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kerr Douglas · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-05 | Sale : show line 1 in the form 10b5-1 | −904 | $14.90 | $13,470 | 171,606 | D |
| Open-market sales · 904 sh · avg $14.90 · $13,470 | ||||||
Loading xslF345X05/ownership.xml…